The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An exploratory analysis of bone scan lesion area (BSLA), circulating tumor cell (CTC) change, pain reduction, and overall survival (OS) in patients (pts) with castration-resistant prostate cancer (CRPC) treated with cabozantinib (cabo): Updated results of a phase II nonrandomized expansion (NRE) cohort.
Howard I. Scher
Consultant or Advisory Role - Aragon Pharmaceuticals (U); Bristol-Myers Squibb; Celgene (U); Dendreon; Endo Pharmaceuticals; Exelixis (U); Foundation Medicine (U); Genentech; Janssen Pharmaceutical (U); Johnson & Johnson (U); Medivation (U); Millennium (U); Novartis; Ortho Biotech; Sanofi ; Senior Scientific; Takeda (U)
Research Funding - Aragon Pharmaceuticals; Bristol-Myers Squibb; Exelixis; Janssen; Janssen Research & Development; Medivation
Matthew R. Smith
Consultant or Advisory Role - Exelixis
Research Funding - Exelixis
Christopher Sweeney
Consultant or Advisory Role - Exelixis (U)
Honoraria - Exelixis
Research Funding - Exelixis
Paul Gettys Corn
No relevant relationships to disclose
Christopher Logothetis
Consultant or Advisory Role - Astellas Pharma
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Johnson & Johnson; Novartis; Pfizer
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Johnson & Johnson; Novartis; Pfizer
Nicholas J. Vogelzang
Consultant or Advisory Role - Exelixis
David C. Smith
Research Funding - Exelixis
Maha Hussain
No relevant relationships to disclose
Daniel J. George
Consultant or Advisory Role - Exelixis
Research Funding - Exelixis
Johann Sebastian De Bono
No relevant relationships to disclose
Celestia S. Higano
Research Funding - Exelixis
Other Remuneration - Exelixis
Eric Jay Small
No relevant relationships to disclose
Jonathan Goldin
Consultant or Advisory Role - Exelixis
Stock Ownership - MedQIA
Matthew S. Brown
Employment or Leadership Position - MedQIA (U)
Consultant or Advisory Role - MedQIA
Stock Ownership - MedQIA
Dana T. Aftab
Employment or Leadership Position - Exelixis
Stock Ownership - Exelixis
Mojtaba Noursalehi
Employment or Leadership Position - Exelixis
Stock Ownership - Exelixis
Aaron Weitzman
Employment or Leadership Position - Exelixis
Stock Ownership - Exelixis
Ethan M. Basch
No relevant relationships to disclose